Mass spectrometry-based analysis of rheumatoid factor

Area of Science:

• Immunology
• Proteomics
• Autoimmune Diseases

Background:

• Rheumatoid factor (RF) are autoantibodies crucial in rheumatoid arthritis (RA) diagnosis.
• Current RF assays lack specificity and harmonization, hindering comprehensive analysis.
• RF targets the Fc portion of immunoglobulin G, but its full diversity is not well understood.

Purpose of the Study:

• To investigate RF heterogeneity and isotypic diversity using mass spectrometry.
• To identify novel RF-associated peptides, including those in variable and hypervariable regions.
• To overcome limitations of conventional solid-phase RF detection methods.

Main Methods:

• Mass spectrometry-based analysis of RF in rheumatoid arthritis (RA) patients and disease controls.
• RF capture, isolation, enzymatic digestion into peptides, and LC-MS/MS analysis.
• Utilized principal component analysis and sparse partial least squares discriminant analysis for data interpretation.

Main Results:

• Differential peptide expression identified between RF-positive RA patients and controls.
• Enrichment of framework, variable, and de novo sequenced peptides in RF-positive sera.
• Mass spectrometry revealed IgA, IgG, and IgM RF isotypes, with IgG2 observed in both RF-positive and RF-negative RA patients.

Conclusions:

• Mass spectrometry offers a powerful platform for characterizing RF heterogeneity and diversity in RA.
• Novel de novo peptides, potentially linked to RF hypervariable regions, were identified.
• Further proteomic and genomic studies are needed to validate these findings and their implications in RA pathogenesis.